| Page 1171 | Kisaco Research
Interview: Dionys Forster
 

Tina Sarén

Senior Scientist
Elicera Therapeutics

Tina Sarén

Senior Scientist
Elicera Therapeutics

Tina Sarén

Senior Scientist
Elicera Therapeutics
 

Alexandra Melia

Partner
Steptoe (UK)

Alexandra Melia

Partner
Steptoe (UK)

Alexandra Melia

Partner
Steptoe (UK)
 

Paul Ibbett

Scientist II
MiNK Therapeutics

Paul Ibbett

Scientist II
MiNK Therapeutics

Paul Ibbett

Scientist II
MiNK Therapeutics
 

Ann Ager

Professor of Cellular Immunity and Immunotherapy, Division of Infection and Immunity, School of Medicine and Systems Immunity Research Institute
Cardiff University

Ann Ager

Professor of Cellular Immunity and Immunotherapy, Division of Infection and Immunity, School of Medicine and Systems Immunity Research Institute
Cardiff University

Ann Ager

Professor of Cellular Immunity and Immunotherapy, Division of Infection and Immunity, School of Medicine and Systems Immunity Research Institute
Cardiff University
 

Troels Jordansen

CEO
Glycostem Therapeutics

Troels Jordansen

CEO
Glycostem Therapeutics

Troels Jordansen

CEO
Glycostem Therapeutics
 

Sven Kili

CEO
Antion Biosciences

Sven Kili

CEO
Antion Biosciences

Sven Kili

CEO
Antion Biosciences